The funding will support late-stage development of a 'prepandemic vaccine against H5 influenza virus.' Moderna's collaboration aims to expedite mRNA vaccine development for pandemic influenza preparedness.
Moderna CEO highlighted mRNA vaccine technology's benefits in efficacy, development speed, and scalability proven during Covid-19, emphasizing collaboration with BARDA for pandemic influenza preparedness.
[
Collection
]
[
|
...
]